Deerfield Management’s PMV Pharmaceuticals PMVP Stock Holding History

Deerfield Management’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.8K	Hold	8,790	–	–	﹤0.01%	81
2026 Q1	$10.9K	Hold	8,790	–	–	﹤0.01%	80
2025 Q4	$11K	Hold	8,790	–	–	﹤0.01%	148
2025 Q3	$12.3K	Hold	8,790	–	–	﹤0.01%	150
2025 Q2	$9.32K	Buy	+8,790	New	+$8.62K	﹤0.01%	121
2022 Q2	–	Sell	-470	Closed	-$10K	–	133
2022 Q1	$10K	Sell	470 -521,530	-100%	-$9.2M	﹤0.01%	119
2021 Q4	$12.1M	Sell	522,000 -282,000	-35%	-$6.81M	0.25%	77
2021 Q3	$24M	Hold	804,000	–	–	0.47%	61
2021 Q2	$27.5M	Buy	804,000 +380,320	+90%	+$12.7M	0.49%	68
2021 Q1	$13.9M	Buy	423,680 +236,488	+126%	+$9.32M	0.29%	88
2020 Q4	$11.5M	Buy	187,192 +137,192	+274%	+$5.38M	0.23%	96
2020 Q3	$1.77M	Buy	+50,000	New	+$1.84M	0.04%	101

Other funds holding PMVP

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Deerfield Management's PMVP Position: Q2 2026 in Review

Deerfield Management held its PMV Pharmaceuticals (PMVP) position steady in Q2 2026 at 8,790 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #81.

Deerfield Management first reported a position in PMVP in Q3 2020 and has held it in 12 quarters since. The position peaked at $27.5M in Q2 2021. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

Deerfield Management held 8,790 shares of PMV Pharmaceuticals worth $11.8K as of Q2 2026.
Deerfield Management left its PMV Pharmaceuticals share count unchanged in Q2 2026.
PMV Pharmaceuticals made up ﹤0.01% of Deerfield Management's portfolio in Q2 2026, its #81 holding.
Deerfield Management first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 12 quarters since.
Deerfield Management's PMV Pharmaceuticals position peaked at $27.5M in Q2 2021.
64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.